Number of items: 7.
Yes
Mühlebach, S. and Moor, M. J. and Wyss, P. A. and Bickel, M. H..
(1991)
Kinetics of distribution and elimination of DDE in rats.
Xenobiotica, 21 (1).
pp. 111-120.
Mühlebach, S. and Wyss, P. A. and Bickel, M. H..
(1991)
The use of 2,4,5,2',4',5'-hexachlorobiphenyl (6-CB) as an unmetabolizable lipophilic model compound.
Pharmacology and Toxicology, 69 (6).
pp. 410-415.
Wyss, P. A. and Mühlebach, S. and Bickel, M. H..
(1986)
Long-term pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with constant adipose tissue mass.
Drug Metabolism and Disposition, 14 (3).
pp. 361-365.
Mühlebach, S. and Wyss, P. A. and Bickel, M. H..
(1985)
Comparative adipose tissue kinetics of thiopental, DDE and 2,4,5,2',4',5'-hexachlorobiphenyl in the rat.
Xenobiotica, 15 (6).
pp. 485-491.
Jondorf, W. R. and Wyss, P. A. and Mühlebach, S. and Bickel, M. H..
(1983)
Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
Drug Metabolism and Disposition, 11 (6).
pp. 597-601.
Wyss, P. A. and Mühlebach, S. and Bickel, M. H..
(1982)
Pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. I. Effects of restricting food intake two weeks after administration of 6-CB.
Drug Metabolism and Disposition, 10 (6).
pp. 657-661.
Mühlebach, S. and Bickel, M. H..
(1981)
Pharmacokinetics in rats of 2,4,5,2',4',5'-hexachlorobiphenyl, an unmetabolizable lipophilic model compound.
Xenobiotica, 11 (4).
pp. 249-257.
This list was generated on Thu Dec 12 14:11:14 2024 CET.